These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 24079771
1. Metalloproteinases and metalloproteinase inhibitors in age-related diseases. Gargiulo S, Gamba P, Poli G, Leonarduzzi G. Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771 [Abstract] [Full Text] [Related]
2. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. Cells; 2020 May 25; 9(5):. PubMed ID: 32466129 [Abstract] [Full Text] [Related]
3. Matrix Metalloproteinases: How Much Can They Do? Ågren MS, Auf dem Keller U. Int J Mol Sci; 2020 Apr 12; 21(8):. PubMed ID: 32290531 [Abstract] [Full Text] [Related]
4. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease. Zhong S, Khalil RA. Biochem Pharmacol; 2019 Jun 12; 164():188-204. PubMed ID: 30905657 [Abstract] [Full Text] [Related]
6. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Wang X, Khalil RA. Adv Pharmacol; 2018 Jun 12; 81():241-330. PubMed ID: 29310800 [Abstract] [Full Text] [Related]
7. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future. Apte SS, Parks WC. Matrix Biol; 2015 Jun 12; 44-46():1-6. PubMed ID: 25916966 [Abstract] [Full Text] [Related]
9. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. J Enzyme Inhib Med Chem; 2016 Sep 12; 31(sup1):177-183. PubMed ID: 27028474 [Abstract] [Full Text] [Related]
11. MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm. Li Y, Wang W, Li L, Khalil RA. Life Sci; 2020 Jul 15; 253():117659. PubMed ID: 32283055 [Abstract] [Full Text] [Related]
13. Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases. Amar S, Minond D, Fields GB. Proteomics; 2017 Dec 15; 17(23-24):. PubMed ID: 28613012 [Abstract] [Full Text] [Related]
14. Biochemical and Biological Attributes of Matrix Metalloproteinases. Cui N, Hu M, Khalil RA. Prog Mol Biol Transl Sci; 2017 Dec 15; 147():1-73. PubMed ID: 28413025 [Abstract] [Full Text] [Related]
15. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review. Binder MJ, Ward AC. Int J Mol Sci; 2021 Mar 30; 22(7):. PubMed ID: 33808504 [Abstract] [Full Text] [Related]
16. Structure and Function of Human Matrix Metalloproteinases. Laronha H, Caldeira J. Cells; 2020 Apr 26; 9(5):. PubMed ID: 32357580 [Abstract] [Full Text] [Related]